DS
WINT

David Shaw’s Windtree Therapeutics Inc WINT Stock Holding History

David Shaw’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-10,537
Closed -$31K – 3991
2015
Q4 		$31K Sell
10,537
-12,066
-53% -$49.5K ﹤0.01% 3736
2015
Q3 		$95K Buy
22,603
+1
+0% +$7 ﹤0.01% 3616
2015
Q2 		$215K Buy
22,602
+8,526
+61% +$120K ﹤0.01% 3556
2015
Q1 		$235K Sell
14,076
-3,079
-18% -$60.6K ﹤0.01% 3396
2014
Q4 		$279K Sell
17,155
-4,688
-21% -$103K ﹤0.01% 3678
2014
Q3 		$562K Sell
21,843
-2,047
-9% -$49.4K ﹤0.01% 3266
2014
Q2 		$595K Sell
23,890
-1,006
-4% -$25.7K ﹤0.01% 3389
2014
Q1 		$749K Sell
24,896
-22,734
-48% -$765K ﹤0.01% 3276
2013
Q4 		$1.5M Sell
47,630
-5,520
-10% -$173K ﹤0.01% 2795
2013
Q3 		$1.46M Sell
53,150
-4,084
-7% -$99K ﹤0.01% 2706
2013
Q2 		$1.22M Buy
+57,234
New +$1.41M ﹤0.01% 2551

Other funds holding WINT

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

David Shaw's WINT Position: Q1 2016 in Review

David Shaw sold out of Windtree Therapeutics Inc (WINT) in Q1 2016, closing a stake of 10,537 shares — an estimated $31K sold.

David Shaw first reported a position in WINT in Q2 2013 and held it in 11 quarters. The position peaked at $1.5M in Q4 2013. 34 funds tracked by Wall St. Rank hold WINT as of Q1 2016.

  • David Shaw reported no remaining Windtree Therapeutics Inc position as of Q1 2016 after selling out during the quarter.
  • David Shaw sold 10,537 Windtree Therapeutics Inc shares in Q1 2016, an estimated $31K.
  • David Shaw first reported a position in Windtree Therapeutics Inc in Q2 2013 and held it in 11 quarters.
  • David Shaw's Windtree Therapeutics Inc position peaked at $1.5M in Q4 2013.
  • 34 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q1 2016.

Based on D.E. Shaw & Co's 13F filing for Q1 2016, filed 16 May 2016.